Cantor Fitzgerald hosted a healthcare conference on September 8, 2026.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Cantor Fitzgerald →

  American financial services company

  • SoundHound is listed on the Nasdaq stock exchange, and its CEO has outlined the company's acquisition strategy.Mon 04:01
  • Analyst firm lowered price targets on Automatic Data Processing (ADP) stock on June 6, 2026.Sun 18:41

Related events

• Cantor Fitzgerald reiterated an Overweight rating for aTyr Pharma on August 20, 2025.Jun 7
• Cantor Fitzgerald began coverage and issued rating, and Morgan Stanley upgraded price objective and rating for Silence Therapeutics.Wed 20:36
• Cantor Fitzgerald affiliates organized a Special Purpose Acquisition Company (SPAC).Sep 6
• Cantor Fitzgerald and Citigroup issued rating updates, while MarketBeat reported research notes on Quince Therapeutics.Fri 07:37